Christopher Benecchi Sage Therapeutics, Inc. (SAGE) insider trading activity

SAGE Quotes by TradingView

Christopher Benecchi is Chief Business Officer of Sage Therapeutics, Inc.. Currently has a direct ownership of 18,487 shares of SAGE, which is worth approximately $112,400. The most recent transaction as insider was on Aug 05, 2024, when has been sold 4,755 shares (Common Stock) at a price of $8.96 per share, resulting in proceeds of $42,604. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18.5K
4.85% 3M change
251.46% 12M change
Total Value Held $112,400

Christopher Benecchi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 05 2024
SELL
Payment of exercise price or tax liability
$42,604 $8.96 p/Share
4,755 Reduced 20.46%
18,487 Common Stock
Aug 05 2024
BUY
Grant, award, or other acquisition
-
16,200 Added 41.07%
23,242 Common Stock
Feb 13 2024
BUY
Grant, award, or other acquisition
-
13,500 Added 41.0%
19,430 Common Stock
Feb 03 2023
SELL
Payment of exercise price or tax liability
$93,575 $44.16 p/Share
2,119 Reduced 28.72%
5,260 Common Stock
Feb 03 2023
BUY
Grant, award, or other acquisition
-
6,750 Added 47.77%
7,379 Common Stock
CB

Christopher Benecchi

Chief Business Officer
Cambridge, MA

Track Institutional and Insider Activities on SAGE

Follow Sage Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SAGE shares.

Notify only if

Insider Trading

Get notified when an Sage Therapeutics, Inc. insider buys or sells SAGE shares.

Notify only if

News

Receive news related to Sage Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SAGE